Global Lipid Disorder Treatment Market, By Product (Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Other), Indication (Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia, Other), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Lipid Disorder Treatment Market
The lipid disorder treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data bridge market research analyses that the market is growing with the CAGR of 6.87% in the forecast period of 2021 to 2028 and is expected to reach USD 37.79 billion by 2028. The increase in prevalence of cardiovascular diseases among population across the globe is escalating the growth of the lipid disorder treatment market.
Lipids refer to the major components of the body made up of hydrocarbons which play an important role in formation and functioning of living cells. These are known to be fat type substances and they reside in the form of oil, vitamins and waxes inside the body. They are commonly known as cholesterol and help in the functioning of the body, especially the cardiovascular system. They could cause harm if not balanced. The improper amount of LDL-cholesterol and triglycerides in the blood stream could cause serious health related issues. The lipid disorder has become one of the fastest increasing health problems worldwide.
The increase in the rate of various lifestyle diseases globally especially, among teens and people in their 50-60 years old, the growing occurrence of high cholesterol and triglycerides causing heart diseases and rise in the demand for safe and efficient treatments for lipid disorders are the major factors driving the lipid disorder treatment market. The increasing incidences of atherosclerosis, heart disease, stroke, obesity and type 2 diabetes among people, the surge in the cases of overweight or obese and growth of familial combined hyperlipidemia incidence rate accelerate the lipid disorder treatment market growth. Additionally, growing population, rise in awareness regarding the disease and treatment, high mortality rate and surge in the healthcare expenditure positively affect the lipid disorder treatment market. Furthermore, technological advancement in the treatment facilities extends profitable opportunity to the lipid disorder treatment market players in the forecast period of 2021 to 2028.
On the other hand, the side effects of the medication involved in the treatment are factors expected to obstruct the lipid disorder treatment market growth. The concerns regarding the muscle problems such as aches, pains, and weakness are projected to challenge the lipid disorder treatment market in the forecast period of 2021 to 2028.
This lipid disorder treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lipid disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Lipid Disorder Treatment Market Scope and Market Size
The lipid disorder treatment market is segmented on the basis of product, indication and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the lipid disorder treatment market is segmented into atorvastatin, fluvastatin, rosuvastatin, simvastatin, pravastatin and other.
- On the basis of indication, the lipid disorder treatment market is segmented into familial combined hyperlipidemia, familial defective apolipoprotein b-100, familial dysbetalipoproteinemia, familial hypertriglyceridemia, heterozygous familial hypercholesterolemia and other.
- On the basis of distribution channel, the lipid disorder treatment market is segmented into retail pharmacies, hospital pharmacies and online pharmacies.
Global Lipid Disorder Treatment Market Country Level Analysis
The lipid disorder treatment market is analyzed and market size insights and trends are provided by country, product, indication and distribution channel as referenced above.
The countries covered in the global lipid disorder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lipid disorder treatment market because of the presence of key players, established healthcare infrastructure, higher incidence of familial combined hyperlipidemia, high prevalence of obesity and other lifestyle disorder, increase in awareness of the treatment and government initiatives in the region.
The country section of the lipid disorder treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The lipid disorder treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lipid disorder treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on lipid disorder treatment market. The data is available for historic period 2011-2019.
Competitive Landscape and Lipid Disorder Treatment Market Share Analysis
The lipid disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lipid disorder treatment market.
The major players covered in the lipid disorder treatment market report are Pfizer Inc., Novartis AG, AstraZeneca, Merck & Co., Inc., Emcure Pharmaceuticals, Ranbaxy Laboratories, Teva Pharmaceutical Industries Ltd., Mylan N.V., Viatris Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Ltd., WOCKHARDT, Aurobindo Pharma, Amgen Inc., GlaxoSmithKline plc, Biocon, Concord Biotech among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-